Pharm
Prednisolone
search
Prednisolone
, Pediapred, Orapred
See Also
Systemic Corticosteroid
Topical Corticosteroid
Inhaled Corticosteroid
Intranasal Steroid
Intra-articular Corticosteroid
Corticosteroid Associated Osteoporosis
Stress Dose Steroid
Steroid-Induced Hyperglycemia
Indications
Acute
Asthma Exacerbation
Anti-inflammatory and Immunosuppresive Agent
Nephrotic Syndrome
Multiple Sclerosis
Primary
Adrenal Insufficiency
Mechanism
See
Systemic Corticosteroid
Prednisolone, other than not requiring first-pass metabolism, is identical to its prodrug
Prednisone
Intermediate activity duration (longer than
Hydrocortisone
, shorter than
Dexamethasone
)
Intermediate
Glucocorticoid
(5 fold more than
Hydrocortisone
) activity
Low mineralcorticoid activity (half that of
Hydrocortisone
)
Medications
Prednisolone (Prelone) Tablets: 5 mg
Prednisolone (Orapred ODT) Orally Disintegrating Tablets: 10 mg, 15 mg, 30 mg
Prednisolone (Prelone) Syrup: 15 mg/5 ml
Prednisolone (Prelone, Pediapred) Solution: 5 mg/5 ml, 10 mg/5 ml, 15 mg/5 ml, 20 mg/5ml, 25 mg 5 ml
Other non-systemic formulations
See
Ophthalmic Corticosteroid
(for Prednisolone acetate drops)
Dosing
Gene
ral
See specific conditions for dosing protocols
Prednisone
dosing is equivalent to Prednisolone dosing
Adult
Dose 5 to 60 mg orally daily
Child
Dose: 1-2 mg/kg/day (up to 60 mg/day) orally daily or divided twice daily
Maximum: 60 mg per day
Pharmacokinetics
Requires no first pass metabolism via the liver (unlike
Prednisone
)
Medium potency
Medium anti-inflammatory potency
Has
Mineralocorticoid
Activity
Medium
Half-Life
(~36 hours)
Adverse Effects
See
Systemic Corticosteroid
Safety
See
Systemic Corticosteroid
Pregnancy Category C
Considered safe in
Lactation
Resources
Prednisolone Table and Solutions (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3115aef0-fd50-4ec8-a064-3effb695f3f2
Prednisolone Syrup (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86652e2d-664a-4388-a611-c2a9aa4a4bc8
Prednisolone ODT or Orapred ODT (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e379543-c4cf-4e72-953b-db15b7f0c2a1
References
Swadron and Hope in Herbert (2018) EM:Rap 18(9):16-8
Dvorin (2020) Am Fam Physician 101(2): 89-94 [PubMed]
Lane (1998) Endocrinol Metab Clin North Am 27:465-83 [PubMed]
Type your search phrase here